| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
ANGPT1
|
angiopoietin 1
|
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCORL1
|
BCL6 corepressor-like 1
|
|
BCR
|
breakpoint cluster region
|
|
BEX1
|
brain expressed, X-linked 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMF
|
Bcl2 modifying factor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRD1
|
bromodomain containing 1
|
|
BSG
|
basigin (Ok blood group)
|
|
CADM1
|
cell adhesion molecule 1
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCNA1
|
cyclin A1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD160
|
CD160 molecule
|
|
CD19
|
CD19 molecule
|
|
CD274
|
CD274 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD5
|
CD5 molecule
|
|
CD7
|
CD7 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD8A
|
CD8a molecule
|
|
CD96
|
CD96 molecule
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN5
|
claudin 5
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CUEDC2
|
CUE domain containing 2
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CXXC5
|
CXXC finger protein 5
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DEFB1
|
defensin, beta 1
|
|
DEK
|
DEK proto-oncogene
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DMTF1
|
cyclin D binding myb-like transcription factor 1
|
|
DNM1L
|
dynamin 1-like
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
E2F1
|
E2F transcription factor 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ELANE
|
elastase, neutrophil expressed
|
|
EPHB6
|
EPH receptor B6
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXL2
|
F-box and leucine-rich repeat protein 2
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOXM1
|
forkhead box M1
|
|
FOXP3
|
forkhead box P3
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
GABARAPL2
|
GABA(A) receptor-associated protein-like 2
|
|
GADD45GIP1
|
growth arrest and DNA-damage-inducible, gamma interacting protein 1
|
|
GATA2
|
GATA binding protein 2
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNLY
|
granulysin
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPR84
|
G protein-coupled receptor 84
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSX2
|
GS homeobox 2
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMHA1
|
histocompatibility (minor) HA-1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HOXA10
|
homeobox A10
|
|
HOXA7
|
homeobox A7
|
|
HOXA9
|
homeobox A9
|
|
HOXB3
|
homeobox B3
|
|
HOXB4
|
homeobox B4
|
|
HPSE
|
heparanase
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL21
|
interleukin 21
|
|
IL24
|
interleukin 24
|
|
IL3
|
interleukin 3
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF8
|
interferon regulatory factor 8
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JARID2
|
jumonji, AT rich interactive domain 2
|
|
JMJD1C
|
jumonji domain containing 1C
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAT2
|
linker for activation of T cells family, member 2
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LIF
|
leukemia inhibitory factor
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LPL
|
lipoprotein lipase
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
MACROD1
|
MACRO domain containing 1
|
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene)
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAT2A
|
methionine adenosyltransferase II, alpha
|
|
MAT2B
|
methionine adenosyltransferase II, beta
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEIS1
|
Meis homeobox 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIR126
|
microRNA 126
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR196B
|
microRNA 196b
|
|
MIR21
|
microRNA 21
|
|
MIR23A
|
microRNA 23a
|
|
MIR34A
|
microRNA 34a
|
|
MIR365A
|
microRNA 365a
|
|
MIR96
|
microRNA 96
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSX2
|
msh homeobox 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MVP
|
major vault protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
NBAS
|
neuroblastoma amplified sequence
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NGFR
|
nerve growth factor receptor
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRP1
|
neuropilin 1
|
|
NUP98
|
nucleoporin 98kDa
|
|
OCLN
|
occludin
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX5
|
paired box 5
|
|
PBK
|
PDZ binding kinase
|
|
PCM1
|
pericentriolar material 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PEG10
|
paternally expressed 10
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PITX1
|
paired-like homeodomain 1
|
|
PLAC8
|
placenta-specific 8
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLK1
|
polo-like kinase 1
|
|
PLS3
|
plastin 3
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PML
|
promyelocytic leukemia
|
|
PMPCB
|
peptidase (mitochondrial processing) beta
|
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1
|
|
POGLUT1
|
protein O-glucosyltransferase 1
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform
|
|
PPP4C
|
protein phosphatase 4, catalytic subunit
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTH
|
parathyroid hormone
|
|
PVR
|
poliovirus receptor
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SDC2
|
syndecan 2
|
|
SECTM1
|
secreted and transmembrane 1
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETBP1
|
SET binding protein 1
|
|
SFTPD
|
surfactant protein D
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SLC22A16
|
solute carrier family 22 (organic cation/carnitine transporter), member 16
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THPO
|
thrombopoietin
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TJP1
|
tight junction protein 1
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPD52L1
|
tumor protein D52-like 1
|
|
TPD52L2
|
tumor protein D52-like 2
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRIM33
|
tripartite motif containing 33
|
|
TYMS
|
thymidylate synthetase
|
|
UBA7
|
ubiquitin-like modifier activating enzyme 7
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VN1R17P
|
vomeronasal 1 receptor 17 pseudogene
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YBX1
|
Y box binding protein 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
